Results 21 to 30 of about 513,484 (358)

First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. [PDF]

, 2018
PURPOSE: To investigate the utility of 153Sm lexidronam (Quadramet) in the setting of men with prostate cancer status post radical prostatectomy who develop biochemical failure with no clinical evidence of osseous metastases.
Girvigian, Michael R., Hoffman-Censits, Jean, Ko, Eric C., Pugh, Stephanie L., Rosenthal, Seth A., Sandler, Howard M., Sartor, Oliver, Schallenkamp, John, Shaves, Mark E., Trabulsi, Edouard J., Valicenti, Richard K.   +10 more
core   +2 more sources

Radiation oncology in Canada [PDF]

Japanese Journal of Clinical Oncology, 2017
In this article we provide an overview of the Canadian healthcare system and the cancer care system in Canada as it pertains to the governance, funding and delivery of radiotherapy programmes. We also review the training and practice for radiation oncologists, medical physicists and radiation therapists in Canada.
Meredith Giuliani, Meredith Giuliani, Mary Gospodarowicz, Mary Gospodarowicz   +3 more
openaire   +3 more sources

Integrating Radiation Oncology Into Undergraduate Medical Education

Advances in Radiation Oncology, 2021
Cancer is one of the most important public health problems. However, medical education has not advanced at the same rate when it comes to cancer education.
Mona Arbab, MD, Jordan A. Holmes, MD, MPH, Kenneth R. Olivier, MD, Emma C. Fields, MD, Kimberly S. Corbin, MD, Jenna M. Kahn, MD, Richard C. Zellars, MD, Antwione M. Haywood, PhD   +7 more
doaj  

Advanced Glycation End Products’ Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Genetics Research, 2023
Background. Advanced glycation end products’ receptor (AGER) is a multiligand receptor that interacts with a wide range of ligands. Previous studies have shown that abnormal AGER expression is closely related to immune infiltration and tumorigenesis ...
Jun Yang, Mingqiang Lin, Mengyan Zhang, Zhiping Wang, Hancui Lin, Yilin Yu, Qunhao Zheng, Xiaohui Chen, Yahua Wu, Qiwei Yao, Jiancheng Li   +10 more
doaj   +1 more source

AAPM medical physics practice guideline 10.a.: Scope of practice for clinical medical physics. [PDF]

, 2018
The American Association of Physicists in Medicine (AAPM) is a nonprofit professional society whose primary purposes are to advance the science, education, and professional practice of medical physics.
Anthony Seibert, J, Baird, Christopher T, Clements, Jessica B, de Boer, Steven F, Fairobent, Lynne A, Fisher, Tyler, Goodwin, James H, Gress, Dustin A, Johnson, Jennifer Lynn, Kolsky, Kathryn L, Mageras, Gig S, Marsh, Rebecca M, Martin, Melissa C, Parker, Brent, Pavord, Daniel C, Schell, Michael C, Stevens, Donna M, Tarver, Russell B, Waite-Jones, Christopher G, Wingreen, Nicholai   +19 more
core   +1 more source

Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study

Journal of Hepatocellular Carcinoma, 2022
Nalee Kim,1,* Jason Chia-Hsien Cheng,2,* Nitin Ohri,3 Wen-Yen Huang,4 Tomoki Kimura,5 Zhao Chong Zeng,6 Victor Ho Fun Lee,7 Chul Seung Kay,8 Jinsil Seong9 1Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan School of Medicine,
Kim N, Cheng JCH, Ohri N, Huang WY, Kimura T, Zeng ZC, Lee VHF, Kay CS, Seong J   +8 more
doaj  

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

BMC Urology, 2017
Background Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).
Daniel N. Cagney, Mary Dunne, Carmel O’Shea, Marie Finn, Emma Noone, Martina Sheehan, Lesley McDonagh, Lydia O’Sullivan, Pierre Thirion, John Armstrong   +9 more
doaj   +1 more source

Training in Radiation and Clinical Oncology in Europe

Journal of Medical Education and Curricular Development, 2023
The European population is strongly affected by cancer. Radiotherapy is roughly used in 50% of cancer patients in European countries. The increased cancer burden demands a new generation of radiation/clinical oncologist (RO/CO) that, besides a strong ...
Pedro C Lara, Kim Benstead, Jesper Grau Erikssen   +2 more
doaj   +1 more source

A Radiation Oncology Based Electronic Health Record in an Integrated Radiation Oncology Network [PDF]

, 2017
Purpose: The goal of this ongoing project is to develop and integrate a comprehensive electronic health record (EHR) throughout a multi-facility radiation oncology network to facilitate more efficient workflow and improve overall patient care and safety.
Billy, Richard, Colonias, Athanasios, Fuhrer, Russell, Horrigan, T., Karlovits, Stephen M., Luick, Marc, Parda, David S., Strickland, Staci, Trombetta, Mark G., Werts, E. Day   +9 more
core   +3 more sources

Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy

Dose-Response, 2021
The rapid advances in nuclear medicine have resulted in significant advantages for the field of oncology. The focus is on the application of radiopharmaceuticals as therapeuticals.
Ekaterina Nikolova, Dimitar Tonev, Nikolai Zhelev, Vladimir Neychev   +3 more
doaj   +1 more source